Search Results - "Surinova, V I"

In Vitro and In Vivo Antitumor Activities of Isothiourea and Cinnamic Acid Derivative with NOS/MCT Inhibitory Effect by Shitova, A. A., Filimonova, M. V., Soldatova, O. V., Volkova, I. K., Rybachuk, V. A., Shevchenko, L. I., Surinova, V. I., Kaprin, A. D., Shegay, P. V., Ivanov, S. A., Shlyakhto, E. V., Filimonov, A. S.

“…This work presents the method of synthesis and physicochemical characterization of isothiourea and cinnamic acid original derivative α-cyano-4-hydroxycinnamate…”
Get full text

In Vitro Antiviral Activity of a New Indol-3-carboxylic Acid Derivative Against SARS-CoV-2 by Narovlyansky, A N, Filimonova, M V, Tsyshkova, N G, Pronin, A V, Grebennikova, T V, Karamov, E V, Larichev, V F, Kornilayeva, G V, Fedyakina, I T, Dolzhikova, I V, Mezentseva, M V, Isaeva, E I, Poloskov, V V, Koval, L S, Marinchenko, V P, Surinova, V I, Filimonov, A S, Shitova, A A, Soldatova, O V, Sanin, A V, Zubashev, I K, Ponomarev, A V, Veselovsky, V V, Kozlov, V V, Stepanov, A V, Khomich, A V, Kozlov, V S, Ivanov, S A, Shegai, P V, Kaprin, A D, Ershov, F I, Gintsburg, A L

“…The coronavirus disease (COVID-19) pandemic has brought into sharp relief the threat posed by coronaviruses and laid the foundation for a fundamental analysis…”
Get full text

Vasopressor Properties of Nitric Oxide Synthase Inhibitor T1059. Part I: Synthesis, Toxicity, NOS-Inhibition Activity, and Hemodynamic Effects Under Normotensive Conditions by Filimonova, M. V., Shevchenko, L. I., Makarchuk, V. M., Chesnakova, E. A., Surinova, V. I., Shevchuk, A. S., Filimonov, A. S., Kryzhanovskii, S. A., Shevchenko, T. F., Bugrova, A. E., Kalamkarov, G. R.

“…Compound T1059 (1-cyclohexanecarbonyl-2-ethylisothiourea hydrobromide) was found to be water soluble, moderately toxic (i.p. LD 16 and LD 50 of 274 and 380…”
Get full text